Mission Bio flags breakthrough: Transfer of first Tapestri clinical trial-ready CGT assay 07-Feb-2022 By Jane Byrne Mission Bio says it is paving the way for the routine use of its technology in clinical trials on materials to support the next wave of life-saving CGT treatments.